Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(2094)
•••
tylerreddick
X
View Profile
View Bullboard History
Post by
tylerreddick
on Oct 04, 2024 12:21pm
Financing coming soon
This comment from Hopton makes me think they are in the final stages of getting the financing; " While dilution concerns remain, we are confident that our plans will generate significant
...more
(1150)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Oct 03, 2024 6:54pm
RE:RE:RE:RE:Upcoming Trial
Didn't really say it but I'm assuming the "trial" will take us into 2025 and then based on what kind of results we get some period of negotiations with various market players will
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(1150)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Oct 03, 2024 6:50pm
RE:RE:RE:Upcoming Trial
We (at least speaking for myself) cannot afford another outcome like we got from Allergan/Abbvie. Two times nothing still equals nothing. (Maybe there were a few bucks passed hands along the way but
...more
(11)
•••
LakeOromocto
X
View Profile
View Bullboard History
Comment by
LakeOromocto
on Oct 03, 2024 5:40pm
RE:RE:Upcoming Trial
Howie did drsign the last trial with input from Abbvie/allergan. Dont always assume the worst. Trust me he is getting lots of input into this latest trial. GLTA
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Oct 03, 2024 11:44am
RE:Upcoming Trial
If Howie had an ounce of foresight he would talk to any of these interested potential partners design the trial around what they want to see in the results. This includes any current comparators
...more
(2094)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Oct 02, 2024 6:03pm
RE:Upcoming Trial
Thanks for sharing. I assume there was no indication when the trial would start? Encouraging that he is sticking with the "early" 2025 launch. That would place it sometime in the
...more
(1150)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Oct 02, 2024 5:32pm
RE:Upcoming Trial
I assume you did not take the opportunity to ask him how the Allergan agreement got screwed up and when, if ever, it may be straightened out?
(7)
•••
Nitrodouglas
X
View Profile
View Bullboard History
Post by
Nitrodouglas
on Oct 02, 2024 11:52am
Upcoming Trial
Mr. Hopton got back to me, clarified that the upcoming trial would be 3 months. He said it will be a cheaper trial this go around and that they are adding features which will add value. I'm
...more
(2094)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Oct 02, 2024 10:04am
RE:RE:RE:Interview
Why don't you ask them?
(26)
•••
24minus7
X
View Profile
View Bullboard History
Comment by
24minus7
on Oct 02, 2024 8:05am
RE:RE:RE:Interview
Oh, you're telling me! Poor Howard. Bless his heart, he tries so hard, but he's got the interview charisma of a wet baguette. The last one was like watching a car crash in slow motion - you
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Oct 02, 2024 7:56am
RE:RE:Interview
Why not put Chris or Geraldine in front of the microphone!? Howard has never been strong at interviews and the last one was pretty embarrassing. I do not understand why he does not delegate.
(2094)
•••
tylerreddick
X
View Profile
View Bullboard History
Comment by
tylerreddick
on Oct 01, 2024 2:44pm
RE:RE:Interview
Didn't trade at 9.5 cents for long, selling back at 7.5 Howie still sucks, can't even read from a script.
(80)
•••
bealert
X
View Profile
View Bullboard History
Comment by
bealert
on Oct 01, 2024 12:29pm
RE:Interview
No, the CEO wasn't drunk. He would obviously be better with the scalpel than the tongue. Otherwise our share price wouldn't be in the sewer. Today's market activity with SBM is
...more
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Post by
SleepyHoward
on Oct 01, 2024 11:37am
Interview
https://cdn.jwplayer.com/previews/9bNZ6LWD Is the ceo drunk?
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden